Global Pandemic Influenza Vaccine Market Research Report 2025(Status and Outlook)

March 2025 | 164 pages | ID: G7F9A3DB783AEN
Bosson Research

Abstracts

Report Overview

Pandemic influenza vaccines are specialized vaccines designed to protect against influenza viruses that have the potential to cause a global outbreak, known as a pandemic. These vaccines are developed to provide immunity against specific strains of influenza viruses that are identified as posing a significant risk to public health. Pandemic influenza vaccines are typically different from seasonal influenza vaccines due to the unique nature of pandemic strains and the urgency in developing and distributing the vaccine to prevent widespread illness and death. The development of pandemic influenza vaccines involves close collaboration between public health authorities, vaccine manufacturers, and regulatory bodies to ensure timely and effective deployment in the event of a global influenza pandemic.

The market for pandemic influenza vaccines has been experiencing significant growth in recent years due to increasing awareness of the potential impact of a global influenza pandemic and the importance of preparedness measures. Market trends indicate a rising demand for pandemic influenza vaccines driven by factors such as the growing global population, increased international travel, and the constant threat of new influenza strains emerging. Additionally, advancements in vaccine technology and manufacturing processes have contributed to the development of more effective and efficient pandemic influenza vaccines, further fueling market growth. Government initiatives and public health campaigns aimed at promoting vaccination against seasonal and pandemic influenza also play a crucial role in driving market demand for pandemic influenza vaccines.

This report provides a deep insight into the global Pandemic Influenza Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pandemic Influenza Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pandemic Influenza Vaccine market in any manner.

Global Pandemic Influenza Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Sanofi

CSL

GSK

Viatris

AstraZeneca

Hualan Bio

Changchun Institute of Biological

Sinovac

BCHT

Jiangsu GDK

KM Biologics

Market Segmentation (by Type)

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

Market Segmentation (by Application)

6 Months to 3 Years

> 3 Years

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Pandemic Influenza Vaccine Market
• Overview of the regional outlook of the Pandemic Influenza Vaccine Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pandemic Influenza Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pandemic Influenza Vaccine
1.2 Key Market Segments
1.2.1 Pandemic Influenza Vaccine Segment by Type
1.2.2 Pandemic Influenza Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pandemic Influenza Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Pandemic Influenza Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Pandemic Influenza Vaccine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pandemic Influenza Vaccine Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Pandemic Influenza Vaccine Product Life Cycle
3.3 Global Pandemic Influenza Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Pandemic Influenza Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pandemic Influenza Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Pandemic Influenza Vaccine Manufacturing Sites, Area Served, Product Type
3.8 Pandemic Influenza Vaccine Market Competitive Situation and Trends
3.8.1 Pandemic Influenza Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Pandemic Influenza Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Pandemic Influenza Vaccine Industry Chain Analysis
4.1 Pandemic Influenza Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pandemic Influenza Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Pandemic Influenza Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Pandemic Influenza Vaccine Market
5.7 ESG Ratings of Leading Companies
6 Pandemic Influenza Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pandemic Influenza Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Pandemic Influenza Vaccine Market Size Market Share by Type (2020-2025)
6.4 Global Pandemic Influenza Vaccine Price by Type (2020-2025)
7 Pandemic Influenza Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pandemic Influenza Vaccine Market Sales by Application (2020-2025)
7.3 Global Pandemic Influenza Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Pandemic Influenza Vaccine Sales Growth Rate by Application (2020-2025)
8 Pandemic Influenza Vaccine Market Sales by Region
8.1 Global Pandemic Influenza Vaccine Sales by Region
8.1.1 Global Pandemic Influenza Vaccine Sales by Region
8.1.2 Global Pandemic Influenza Vaccine Sales Market Share by Region
8.2 Global Pandemic Influenza Vaccine Market Size by Region
8.2.1 Global Pandemic Influenza Vaccine Market Size by Region
8.2.2 Global Pandemic Influenza Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Pandemic Influenza Vaccine Sales by Country
8.3.2 North America Pandemic Influenza Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Pandemic Influenza Vaccine Sales by Country
8.4.2 Europe Pandemic Influenza Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Pandemic Influenza Vaccine Sales by Region
8.5.2 Asia Pacific Pandemic Influenza Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Pandemic Influenza Vaccine Sales by Country
8.6.2 South America Pandemic Influenza Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Region
8.7.2 Middle East and Africa Pandemic Influenza Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Pandemic Influenza Vaccine Market Production by Region
9.1 Global Production of Pandemic Influenza Vaccine by Region(2020-2025)
9.2 Global Pandemic Influenza Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Pandemic Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pandemic Influenza Vaccine Production
9.4.1 North America Pandemic Influenza Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Pandemic Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pandemic Influenza Vaccine Production
9.5.1 Europe Pandemic Influenza Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Pandemic Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pandemic Influenza Vaccine Production (2020-2025)
9.6.1 Japan Pandemic Influenza Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Pandemic Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pandemic Influenza Vaccine Production (2020-2025)
9.7.1 China Pandemic Influenza Vaccine Production Growth Rate (2020-2025)
9.7.2 China Pandemic Influenza Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Pandemic Influenza Vaccine Product Overview
10.1.3 Sanofi Pandemic Influenza Vaccine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 CSL
10.2.1 CSL Basic Information
10.2.2 CSL Pandemic Influenza Vaccine Product Overview
10.2.3 CSL Pandemic Influenza Vaccine Product Market Performance
10.2.4 CSL Business Overview
10.2.5 CSL SWOT Analysis
10.2.6 CSL Recent Developments
10.3 GSK
10.3.1 GSK Basic Information
10.3.2 GSK Pandemic Influenza Vaccine Product Overview
10.3.3 GSK Pandemic Influenza Vaccine Product Market Performance
10.3.4 GSK Business Overview
10.3.5 GSK SWOT Analysis
10.3.6 GSK Recent Developments
10.4 Viatris
10.4.1 Viatris Basic Information
10.4.2 Viatris Pandemic Influenza Vaccine Product Overview
10.4.3 Viatris Pandemic Influenza Vaccine Product Market Performance
10.4.4 Viatris Business Overview
10.4.5 Viatris Recent Developments
10.5 AstraZeneca
10.5.1 AstraZeneca Basic Information
10.5.2 AstraZeneca Pandemic Influenza Vaccine Product Overview
10.5.3 AstraZeneca Pandemic Influenza Vaccine Product Market Performance
10.5.4 AstraZeneca Business Overview
10.5.5 AstraZeneca Recent Developments
10.6 Hualan Bio
10.6.1 Hualan Bio Basic Information
10.6.2 Hualan Bio Pandemic Influenza Vaccine Product Overview
10.6.3 Hualan Bio Pandemic Influenza Vaccine Product Market Performance
10.6.4 Hualan Bio Business Overview
10.6.5 Hualan Bio Recent Developments
10.7 Changchun Institute of Biological
10.7.1 Changchun Institute of Biological Basic Information
10.7.2 Changchun Institute of Biological Pandemic Influenza Vaccine Product Overview
10.7.3 Changchun Institute of Biological Pandemic Influenza Vaccine Product Market Performance
10.7.4 Changchun Institute of Biological Business Overview
10.7.5 Changchun Institute of Biological Recent Developments
10.8 Sinovac
10.8.1 Sinovac Basic Information
10.8.2 Sinovac Pandemic Influenza Vaccine Product Overview
10.8.3 Sinovac Pandemic Influenza Vaccine Product Market Performance
10.8.4 Sinovac Business Overview
10.8.5 Sinovac Recent Developments
10.9 BCHT
10.9.1 BCHT Basic Information
10.9.2 BCHT Pandemic Influenza Vaccine Product Overview
10.9.3 BCHT Pandemic Influenza Vaccine Product Market Performance
10.9.4 BCHT Business Overview
10.9.5 BCHT Recent Developments
10.10 Jiangsu GDK
10.10.1 Jiangsu GDK Basic Information
10.10.2 Jiangsu GDK Pandemic Influenza Vaccine Product Overview
10.10.3 Jiangsu GDK Pandemic Influenza Vaccine Product Market Performance
10.10.4 Jiangsu GDK Business Overview
10.10.5 Jiangsu GDK Recent Developments
10.11 KM Biologics
10.11.1 KM Biologics Basic Information
10.11.2 KM Biologics Pandemic Influenza Vaccine Product Overview
10.11.3 KM Biologics Pandemic Influenza Vaccine Product Market Performance
10.11.4 KM Biologics Business Overview
10.11.5 KM Biologics Recent Developments
11 Pandemic Influenza Vaccine Market Forecast by Region
11.1 Global Pandemic Influenza Vaccine Market Size Forecast
11.2 Global Pandemic Influenza Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Pandemic Influenza Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Pandemic Influenza Vaccine Market Size Forecast by Region
11.2.4 South America Pandemic Influenza Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Pandemic Influenza Vaccine by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Pandemic Influenza Vaccine Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Pandemic Influenza Vaccine by Type (2026-2033)
12.1.2 Global Pandemic Influenza Vaccine Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Pandemic Influenza Vaccine by Type (2026-2033)
12.2 Global Pandemic Influenza Vaccine Market Forecast by Application (2026-2033)
12.2.1 Global Pandemic Influenza Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Pandemic Influenza Vaccine Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pandemic Influenza Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Pandemic Influenza Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Pandemic Influenza Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Pandemic Influenza Vaccine Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pandemic Influenza Vaccine as of 2024)
Table 10. Global Market Pandemic Influenza Vaccine Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Pandemic Influenza Vaccine Manufacturing Sites and Area Served
Table 12. Manufacturers Pandemic Influenza Vaccine Product Type
Table 13. Global Pandemic Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Pandemic Influenza Vaccine Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Pandemic Influenza Vaccine Sales by Type (K MT)
Table 25. Global Pandemic Influenza Vaccine Market Size by Type (M USD)
Table 26. Global Pandemic Influenza Vaccine Sales (K MT) by Type (2020-2025)
Table 27. Global Pandemic Influenza Vaccine Sales Market Share by Type (2020-2025)
Table 28. Global Pandemic Influenza Vaccine Market Size (M USD) by Type (2020-2025)
Table 29. Global Pandemic Influenza Vaccine Market Size Share by Type (2020-2025)
Table 30. Global Pandemic Influenza Vaccine Price (USD/MT) by Type (2020-2025)
Table 31. Global Pandemic Influenza Vaccine Sales (K MT) by Application
Table 32. Global Pandemic Influenza Vaccine Market Size by Application
Table 33. Global Pandemic Influenza Vaccine Sales by Application (2020-2025) & (K MT)
Table 34. Global Pandemic Influenza Vaccine Sales Market Share by Application (2020-2025)
Table 35. Global Pandemic Influenza Vaccine Market Size by Application (2020-2025) & (M USD)
Table 36. Global Pandemic Influenza Vaccine Market Share by Application (2020-2025)
Table 37. Global Pandemic Influenza Vaccine Sales Growth Rate by Application (2020-2025)
Table 38. Global Pandemic Influenza Vaccine Sales by Region (2020-2025) & (K MT)
Table 39. Global Pandemic Influenza Vaccine Sales Market Share by Region (2020-2025)
Table 40. Global Pandemic Influenza Vaccine Market Size by Region (2020-2025) & (M USD)
Table 41. Global Pandemic Influenza Vaccine Market Size Market Share by Region (2020-2025)
Table 42. North America Pandemic Influenza Vaccine Sales by Country (2020-2025) & (K MT)
Table 43. North America Pandemic Influenza Vaccine Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Pandemic Influenza Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. Europe Pandemic Influenza Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Pandemic Influenza Vaccine Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Pandemic Influenza Vaccine Market Size by Region (2020-2025) & (M USD)
Table 48. South America Pandemic Influenza Vaccine Sales by Country (2020-2025) & (K MT)
Table 49. South America Pandemic Influenza Vaccine Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Pandemic Influenza Vaccine Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Pandemic Influenza Vaccine Market Size by Region (2020-2025) & (M USD)
Table 52. Global Pandemic Influenza Vaccine Production (K MT) by Region(2020-2025)
Table 53. Global Pandemic Influenza Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2020-2025)
Table 55. Global Pandemic Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Pandemic Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Pandemic Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Pandemic Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Pandemic Influenza Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Sanofi Basic Information
Table 61. Sanofi Pandemic Influenza Vaccine Product Overview
Table 62. Sanofi Pandemic Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Sanofi Business Overview
Table 64. Sanofi SWOT Analysis
Table 65. Sanofi Recent Developments
Table 66. CSL Basic Information
Table 67. CSL Pandemic Influenza Vaccine Product Overview
Table 68. CSL Pandemic Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. CSL Business Overview
Table 70. CSL SWOT Analysis
Table 71. CSL Recent Developments
Table 72. GSK Basic Information
Table 73. GSK Pandemic Influenza Vaccine Product Overview
Table 74. GSK Pandemic Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. GSK Business Overview
Table 76. GSK SWOT Analysis
Table 77. GSK Recent Developments
Table 78. Viatris Basic Information
Table 79. Viatris Pandemic Influenza Vaccine Product Overview
Table 80. Viatris Pandemic Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Viatris Business Overview
Table 82. Viatris Recent Developments
Table 83. AstraZeneca Basic Information
Table 84. AstraZeneca Pandemic Influenza Vaccine Product Overview
Table 85. AstraZeneca Pandemic Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. AstraZeneca Business Overview
Table 87. AstraZeneca Recent Developments
Table 88. Hualan Bio Basic Information
Table 89. Hualan Bio Pandemic Influenza Vaccine Product Overview
Table 90. Hualan Bio Pandemic Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. Hualan Bio Business Overview
Table 92. Hualan Bio Recent Developments
Table 93. Changchun Institute of Biological Basic Information
Table 94. Changchun Institute of Biological Pandemic Influenza Vaccine Product Overview
Table 95. Changchun Institute of Biological Pandemic Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Changchun Institute of Biological Business Overview
Table 97. Changchun Institute of Biological Recent Developments
Table 98. Sinovac Basic Information
Table 99. Sinovac Pandemic Influenza Vaccine Product Overview
Table 100. Sinovac Pandemic Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Sinovac Business Overview
Table 102. Sinovac Recent Developments
Table 103. BCHT Basic Information
Table 104. BCHT Pandemic Influenza Vaccine Product Overview
Table 105. BCHT Pandemic Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. BCHT Business Overview
Table 107. BCHT Recent Developments
Table 108. Jiangsu GDK Basic Information
Table 109. Jiangsu GDK Pandemic Influenza Vaccine Product Overview
Table 110. Jiangsu GDK Pandemic Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Jiangsu GDK Business Overview
Table 112. Jiangsu GDK Recent Developments
Table 113. KM Biologics Basic Information
Table 114. KM Biologics Pandemic Influenza Vaccine Product Overview
Table 115. KM Biologics Pandemic Influenza Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. KM Biologics Business Overview
Table 117. KM Biologics Recent Developments
Table 118. Global Pandemic Influenza Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 119. Global Pandemic Influenza Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 120. North America Pandemic Influenza Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 121. North America Pandemic Influenza Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 122. Europe Pandemic Influenza Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 123. Europe Pandemic Influenza Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Asia Pacific Pandemic Influenza Vaccine Sales Forecast by Region (2026-2033) & (K MT)
Table 125. Asia Pacific Pandemic Influenza Vaccine Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. South America Pandemic Influenza Vaccine Sales Forecast by Country (2026-2033) & (K MT)
Table 127. South America Pandemic Influenza Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Middle East and Africa Pandemic Influenza Vaccine Sales Forecast by Country (2026-2033) & (Units)
Table 129. Middle East and Africa Pandemic Influenza Vaccine Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Global Pandemic Influenza Vaccine Sales Forecast by Type (2026-2033) & (K MT)
Table 131. Global Pandemic Influenza Vaccine Market Size Forecast by Type (2026-2033) & (M USD)
Table 132. Global Pandemic Influenza Vaccine Price Forecast by Type (2026-2033) & (USD/MT)
Table 133. Global Pandemic Influenza Vaccine Sales (K MT) Forecast by Application (2026-2033)
Table 134. Global Pandemic Influenza Vaccine Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Pandemic Influenza Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pandemic Influenza Vaccine Market Size (M USD), 2024-2033
Figure 5. Global Pandemic Influenza Vaccine Market Size (M USD) (2020-2033)
Figure 6. Global Pandemic Influenza Vaccine Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pandemic Influenza Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pandemic Influenza Vaccine Product Life Cycle
Figure 13. Pandemic Influenza Vaccine Sales Share by Manufacturers in 2024
Figure 14. Global Pandemic Influenza Vaccine Revenue Share by Manufacturers in 2024
Figure 15. Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Pandemic Influenza Vaccine Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pandemic Influenza Vaccine Revenue in 2024
Figure 18. Industry Chain Map of Pandemic Influenza Vaccine
Figure 19. Global Pandemic Influenza Vaccine Market PEST Analysis
Figure 20. Global Pandemic Influenza Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pandemic Influenza Vaccine Market Share by Type
Figure 27. Sales Market Share of Pandemic Influenza Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Pandemic Influenza Vaccine by Type in 2024
Figure 29. Market Size Share of Pandemic Influenza Vaccine by Type (2020-2025)
Figure 30. Market Size Share of Pandemic Influenza Vaccine by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pandemic Influenza Vaccine Market Share by Application
Figure 33. Global Pandemic Influenza Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Pandemic Influenza Vaccine Sales Market Share by Application in 2024
Figure 35. Global Pandemic Influenza Vaccine Market Share by Application (2020-2025)
Figure 36. Global Pandemic Influenza Vaccine Market Share by Application in 2024
Figure 37. Global Pandemic Influenza Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pandemic Influenza Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Pandemic Influenza Vaccine Market Size Market Share by Region (2020-2025)
Figure 40. North America Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pandemic Influenza Vaccine Sales Market Share by Country in 2024
Figure 43. North America Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pandemic Influenza Vaccine Market Size Market Share by Country in 2024
Figure 45. U.S. Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pandemic Influenza Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pandemic Influenza Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pandemic Influenza Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pandemic Influenza Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pandemic Influenza Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pandemic Influenza Vaccine Market Size Market Share by Country in 2024
Figure 55. Germany Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pandemic Influenza Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pandemic Influenza Vaccine Market Size Market Share by Region in 2024
Figure 68. China Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pandemic Influenza Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Pandemic Influenza Vaccine Sales Market Share by Country in 2024
Figure 80. South America Pandemic Influenza Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Pandemic Influenza Vaccine Market Size Market Share by Country in 2024
Figure 82. Brazil Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pandemic Influenza Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pandemic Influenza Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pandemic Influenza Vaccine Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pandemic Influenza Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pandemic Influenza Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pandemic Influenza Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Pandemic Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pandemic Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pandemic Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pandemic Influenza Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pandemic Influenza Vaccine Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Pandemic Influenza Vaccine Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Pandemic Influenza Vaccine Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Pandemic Influenza Vaccine Market Share Forecast by Type (2026-2033)
Figure 111. Global Pandemic Influenza Vaccine Sales Forecast by Application (2026-2033)
Figure 112. Global Pandemic Influenza Vaccine Market Share Forecast by Application (2026-2033)